1Vote!
Business Wire (Free subscription) | yesterday
This new report focuses on the market potential for sterile drugs delivered by injection or infusion. These drugs are used to treat major illnesses, such as cancer, central nervous system (CNS) disorders, acute cardiovascular conditions and severe infections. More than one third of the injectable generics approved in the US during the last five years are used in cancer therapy. A further 23% are anti-infectives,...
+Vote!
The Economist (Free subscription) | yesterday
Sales of generic drugs are booming THE generic-drugs industry is in the midst of a dealmaking frenzy. The latest came this month as Teva, the world's largest manufacturer of generics, made an offer worth over $7 billion for Barr, an American rival. Another firm, Actavis has swallowed over two dozen rivals in a decade to become a global force. The opening up of uncompetitive markets, such as Japan...
+Vote!
The Economist (Free subscription) | 07/24/2008
Liberalisation and the quest for scale are pushing generic-drugs firms to merge "THE mighty Israeli Pacman gobbles down another one." That is how analysts at Credit Suisse, an investment bank, greeted news of the latest takeover bid by Teva, an Israeli firm that is already the world's largest generic-drugs manufacturer. The offer, for Barr, an American rival, is valued at more than $7 billion. Success...
1Vote!
Financial Time (Free subscription) | 07/24/2008
GlaxoSmithKline's shift into generic drugs by means of its partnership with Aspen reflects and develops a trend during recent years by large pharmaceutical companies...
1Vote!
The Consumerist (Free subscription) | 07/24/2008
The WSJ Health Blog says that pharmacy benefit managers are marking up the amount they charge your insurance company for generic drugs and keeping the difference. Often the mark-up isn't too severe,... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
+Vote!
The Herald (Free subscription) | 07/24/2008
GlaxoSmithkline, the world’s second-largest drug maker, posted a 3% fall in second-quarter net profit yesterday after strong competition from generic drugs outweighed asset sales and the cost-saving effects of job cuts.
1Vote!
Hindu (Free subscription) | 07/23/2008
LONDON: GlaxoSmithKline, the world’s second largest drugmaker, on Wednesday took a bold step into the branded generics marketplace via an alliance with South Africa’s Aspen Pharmacare Holdings. The move, is the latest sign of Glaxo ...
+Vote!
Chemical and Engineering News (Free subscription) | 07/23/2008
Deal is latest consolidation move in generic drugs sector
1Vote!
The Pittsburgh Business Times (Free subscription) | 07/23/2008
Competition from generic drugs weighed on GlaxoSmithKline's bottom line in the second quarter, the pharmaceutical company said Wednesday. (GSK)
+Vote!
The Triangle Business Journal (Free subscription) | 07/23/2008
Competition from generic drugs weighed on GlaxoSmithKline's bottom line in the second quarter, the pharmaceutical company said Wednesday. (GSK)
+Vote!
ABC News (Free subscription) | 07/23/2008
Lawmakers are probing the agency's approval of Ranbaxy generic drugs.
+Vote!
The Telegraph (Free subscription) | 07/23/2008
GlaxoSmithKline teams up with Aspen to drive generic drugs
+Vote!
Buyer Behaviour (Free subscription) | 07/23/2008
Its the image they bring along. The cash in Parliament drama has been a shameful episode that sullies the image of politicians as a whole, putting it in poor light, though the reality may be something completely different. There are of course politicians who are unblemished with spotless records. Well, you may ask who? The answer, how many members of the house do you know? Though Ranbaxy insists that...
1Vote!
Israelated - English Israel blogs (Free subscription) | 07/22/2008
According to Haaretz, Teva has been going on a “little” shopping spree, buying companies as if they were cute pairs of shoes they just had to have. (And FYI, this Teva company has no connection to the Israeli hikers’ beloved Teva sandal co., incidentally made in China.) Recently, Teva purchased Barr Pharmaceuticals, “the fourth largest generic firm in the U.S., for $7.46 billion.” Teva had previously...
2Vote!
caverta | 07/12/2008
Shoppillrx is a global pharmacy referral service based in Switzerland. It is the incontestable leader in the class of generic drugs insurance with reliable, quality and economic online pharmaceutical services. Shoppillrx provides a handy, globally accessible and affordable means for conquest the latest drug therapy for cure-all affecting millions of people world-wide. Shoppillrx is a licensed pharmacy...
1Vote!
nitesh | 05/31/2008
In 2006, Teva Pharmaceutical Industries generated $8408m in net sales worldwide from both innovative branded and generic drugs, firmly establishing itself as a Top-20 international pharmaceutical company and leader in generics. That performance reflects rapid growth in recent years, as represented by a tripling in sales from $2519m in 2002. By 2010, total sales for Teva should reach $13.3bn. These...
